Patient Innovations Appoints John Tabone Chairman & Chief Executive Officer

18 May 2019

Patient Innovations, an innovative New York based healthcare IT company supporting physicians and health systems, has announced the appointment of John M. Tabone as Chairman and Chief Executive Officer. Mr. Tabone will drive Patient Innovations vision and growth strategy. His responsibilities will include creating the company’s technology roadmap and product evolution as well as all growth-related investments and strategic alignments. 

Ken Greenberg, Co-founder and President, said: “As Patient Innovations evolves its platform and broadens its ecosystem of solutions to meet the growing needs of providers and patients, John’s vision and proven leadership will drive our growth. He is deeply passionate about healthcare and his experience with provider groups and health systems with both private and public multi-national companies will be pivotal to our successful evolution as we scale the company. 

“This is an exciting time to join Patient Innovations”, said Tabone. “Patient Innovations initial seed investment from United Healthcare launched the company to pilot its initial platform predicate of eliminating patient waiting time and improving patient experience. Our interoperable Real-Time Location Services (RTLS) platform, OnTime Care Vista, has multiple high-value use cases and is designed with deep clinical and operational insights and proprietary algorithms to optimize scheduling density, asset utilization and compliance adoption to increase physician panel sizes and trap leakage. We manage encounter and clinical information at scale and our persisted datasets provide insights that drive Clinical Decision Support.” 

Patient Innovations focus is on reimagining access and delivery to minimize physician burnout by eliminating workflow redundancies. Our proprietary acuity-based triage algorithms and appointment allocation methodology, along with our interactive communications platform, facilitates load balancing to improve practice efficiency and patient experience. Tabone said, “Our intelligent platform of tech-enabled innovations is reimagining how we engage with patients, increase efficiency and lower operating costs while optimizing the utility of the clinical workforce.”

“I’m excited to be part of an amazing team and to lead the company at this inflection point in its history. I am honored to work with such an outstanding Advisory Board of industry leading physicians and executives that will provide us with contemporary and practical insights to drive clinical and technological innovations”, said Tabone.

Tabone has spent decades in healthcare holding multiple transformational C-Suite leadership roles with multi-geography P&L responsibility across a broad range of economic cycles for privately held firms and public multi-national companies. He has led merger and acquisition teams, has extensive private equity and investment banking experience and has led numerous joint ventures, strategic alliances and asset purchases. Tabone has deep familiarity with highly regulated, complex and competitive environments. He was most recently the Chief Growth Officer of an outsourcing company engaged in providing operational and clinical support for physicians. Previously, he held roles of Managing Partner of a healthcare investment banking firm and was the CEO of an acquisition company where he led and secured a private equity, and Fortune 100 company, commitment for a $1.3 Billion bid to acquire an international global medical device company. He was the Executive Vice President of a New York Merchant Bank and was responsible for executing investments across several industry verticals including Healthcare and Life Sciences.

Tabone was an executive at Olympus America, a preeminent multi-national medical device company with a leading global market share across numerous diagnostic, therapeutic and interventional asset classes including a broad portfolio of healthcare services. During his sixteen year tenure he held numerous leadership positions including being a Corporate Officer, Board Chairman and Board Director, Chief Financial Officer, Chief Risk Officer, Chief Investment Officer and Treasurer. John was the Founder and Group Head of Olympus’s largest, and most profitable, healthcare services business in the Americas. He changed the entire go-to-market strategy and delivery paradigm which resulted in maintaining dominant share across markets while avoiding mature market margin decay. John also created a capital markets group, managed banking and rating agency relationships and led multiple M&A engagements, Joint Ventures and business combinations. 

Tabone holds a Bachelor of Science Degree from the City University of New York and an MBA in Finance from Long Island University, CW Post Graduate School of Business. He is a member of Delta Mu Delta. John attended the Kellogg School of Management at Northwestern University for the Advanced Executive Program, The Wharton School at the University of Pennsylvania for Healthcare Economics, Management and Policy and Leonard N. Stern School of Business at New York University for Enterprise Risk Management.